Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2017/0246252 Methods of Using Interleukin-10 for Treating Diseases and Disorders
Methods of treating subjects having a disease or disorder responsive to IL-10, including methods of administration and dosing regimens associated therewith,...
2017/0246251 THERAPEUTIC IL-13 POLYPEPTIDES
Variant IL-13 polypeptides are provided, which are engineered to have one or more of the following properties: (a) altered affinity for IL-13R.alpha.2,...
2017/0246250 ELUTING MATRIX AND USES THEREOF
CXCL12 polypeptide eluting matrices encapsulating at least one cell are described for use in the treatment of autoimmune disorders.
2017/0246249 Compositions and Methods of Use for Treating Metabolic Disorders
Methods of treating individuals with a glucose metabolism disorder and/or a body weight disorder, and compositions associated therewith, are provided.
2017/0246248 OLIGOPEPTIDIC COMPOUNDS AND USES THEREOF
Disclosed is A method of treatment of a disorder or condition where it is desirable to inhibit the growth of cells, or a method of treatment which involves...
2017/0246247 Use Of SCO-Spondin Peptides For Inhibiting Or Preventing Neuronal Apoptosis Mediated By Cell Death Receptor Ligands
The invention relates to a polypeptide derived from the TSR (thrombospondin type 1 units) of SCO-Spondin for inhibiting or preventing apoptosis mediated by the...
2017/0246246 COMPOSITIONS AND METHODS FOR INHIBITING INTERCELLULAR INTERACTIONS
Disclosed are compositions and methods involving the use of PRG4 protein, also known as lubricin, to mechanically inhibit biological processes involving cell...
2017/0246245 NOVEL PHARMACEUTICAL COMPOSITION FOR TREATING ALZHEIMER'S DISEASE
The present invention relates to a pharmaceutical composition, and more specifically, to a novel pharmaceutical composition for treating Alzheimer's disease...
2017/0246244 Charged Nutritive Proteins and Methods
Charged nutritive proteins are provided. In some embodiments the nutritive proteins an aqueous solubility of at least 12.5 g/L at pH 7. In some embodiments the...
2017/0246243 BIORESORBABLE SCAFFOLD FOR TREATMENT OF BIFURCATION LESION
Bioresorbable scaffolds for treatment of bifurcation lesion are described herein. Generally, an expandable scaffold may be fabricated from a high molecular...
2017/0246242 PHARMACEUTICAL CYCLOSPORIN COMPOSITIONS
An oral cyclosporin composition comprises minicapsules having a core containing a cyclosporin, especially cyclosporin A in a solubilised liquid form. The...
2017/0246241 Methods for the Selective Treatment of Tumors by Calcium-Mediated Induction of Apoptosis
Tumor cells exhibit consistent abnormalities in calcium regulation. The present disclosure teaches methods by which such differences are exploited to induce...
2017/0246240 Antibacterial Peptide and Method of Treatment Using the Antibacterial Peptide
A method of treating or preventing a bacterial infection in an animal comprises administering to the animal an effective amount of an antibacterial peptide,...
2017/0246239 ANTI-BLEPHARITIS COMPOSITIONS AND THEIR USE
Compositions and methods for the prevention and treatment of blepharitis, where the compositions include verbascoside, oligopeptide-10, and sulfonated shale...
2017/0246238 NEUROKININ 1 RECEPTOR AGONIST MEDIATED PROTECTION OF THE EYE
Neurokinin 1 receptor (NK1R) agonist mediated protection of the eye is described. The protection can reduce dry eye and ocular infections, particularly in...
2017/0246237 SELF-ASSEMBLING TRIPEPTIDES
The present invention relates to a method of predicting the propensity of tripeptides to from aggregates in solution. The present invention also provides...
2017/0246236 METHODS AND COMPOSITIONS FOR ENHANCED DELIVERY OF COMPOUNDS
Disclosed are compositions and methods related to multivalent compositions targeted to cells and tissues. The disclosed targeting is useful for treatment of...
2017/0246235 GREEN TEA COMPOSITIONS
Disclosed herein are green tea plant material extracts, and methods of using the extracts, comprising at least one green tea catechin selected from the group...
2017/0246234 METHODS OF USING WATER SOLUBLE TEA EXTRACTS TO IMPROVE MUSCLE PERFORMANCE, STRESS RESPONSE, AND RECOVERY...
The present invention relates to methods for improving muscle performance wherein a subject is administered an efficacious dose of a mixture of water soluble...
2017/0246233 METHOD OF DECREASING BLOOD SUGAR
The invention relates to a method of decreasing blood sugar by inhibition of .alpha.-glucosidase activity in a subject in need thereof, comprising ...
2017/0246232 TOPICAL HEALING AND SCAR TREATMENT COMPOSITION
Topical aqueous compositions are effective in minimizing scar formation and improving the visual appearance of scars. The compositions are also effective in...
2017/0246231 METHODS FOR TREATING NEUROLOGICAL DISORDERS USING NUTRIENT COMPOSITIONS
Nutrient compositions comprising botanical extracts and an omega 3 fatty acid as well as methods of their use for treating, inter alia, autism or apraxia...
2017/0246230 PHARMACEUTICAL COMPOSITION FOR TREATING INFERTILITY, AND PREPARATION METHOD AND USE THEREOF
The present invention provides a drug combination for the treatment of infertility and its crude drug comprises the medical ingredients with their weight...
2017/0246229 EXTRACTS OF NANNOCHLOROPSIS SP. AND THEIR APPLICATIONS
New extracts of Nannochloropsis sp. and related species of Nannochloropsis are suggested, obtainable by treating said microalgae with a solvent selected from...
2017/0246228 METHOD FOR SUPPRESSING PROLIFERATION AND/OR INDUCING APOPTOSIS OF CANCER CELLS
It is to provide an agent for suppressing proliferation and/or inducing apoptosis of cancer cells that can be used for the treatment and chemoprophylaxis of...
2017/0246227 COMBINATION COMPRISING SPIRULINA AND PALMITOYLETHANOLAMIDE AND/OR SALTS OR PHARMACEUTICALLY ACCEPTABLE...
The present invention relates to the combination of spirulina and palmitoylethanolamide (PEA) and/or pharmaceutically acceptable derivates or salts thereof,...
2017/0246226 COMPOSITIONS AND METHOD FOR TREATMENT AND PROPHYLAXIS OF INFLAMMATORY BOWEL DISEASE
Methods and compositions for treating inflammatory bowel disease involve the use of targeted antibiotics in combination with probiotic formulations. The...
2017/0246225 ORAL COMPOSITION CONTAINING BIFIDOBACTERIA AND CRUCIFEROUS VEGETABLE
Further enhancement in useful effects of Bifidobacteria. An oral composition comprising (A) Bifidobacterium breve MCC1274 (FERM BP-11175) and (B) at least one...
2017/0246224 DIRECT-FED MICROBIALS
The invention relates to direct-fed microbials for use in E. coli inhibition in animals. More particularly, the invention relates to isolated Bacillus strains...
2017/0246223 Combination Therapy for Solid Tumour Cancer
A combination comprising an effective dose of a chemotherapeutic-activating wild-type bacterium and an effective dose of a chemotherapeutic agent that is...
2017/0246222 Bacillus Strains with Fast Germination and Antimicrobial Activity against Clostridium
The present invention relates to compositions such as an animal feed comprising one or more bacteria with fast germination and with anti-Clostridium...
2017/0246221 ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA
The invention relates to methods, uses, systems, arrays, engineered nucleotide sequences and vectors for inhibiting bacterial population growth or for altering...
2017/0246220 BUTYRATE-PRODUCING BACTERIUM AND USE THEREOF
A butyrate-producing bacterium belonging to Anaerostipes hadrus is provided. The amount of butyrate produced is at least 1.5 times that of Anaerostipes hadrus...
2017/0246219 BIOEFFECTIVE KRILL OIL COMPOSITIONS
This invention discloses new krill oil compositions characterized by having high amounts of phospholipids, astaxanthin esters and/or omega-3 contents. The...
2017/0246218 OPHTHALMIC COMPOSITIONS
The present invention discloses novel ophthalmic preparations for the treatment of corneal pathologies comprising umbilical cord blood plasma.
2017/0246217 USE OF CORD BLOOD PLASMA TO TREAT NK CELL-MEDIATED DISEASES AND IFN-γ MEDIATED DISEASES
The present invention shows that CB plasma contains soluble NKG2D ligands and that the incubation of PBMCs with CB plasma results in decreased cytotoxicity,...
2017/0246216 HUMAN AMNIOTIC FLUID PREPARATION HAVING LONG-TERM STABILITY
Methods of preparing sterile de-cellularized human amniotic fluid that is amenable for long-term storage without loss of biological functions have been...
2017/0246215 REPOPULATION OF ORGANS AND TISSUES USING A YAP-ERT2 FUSION PROTEIN
Provided herein are methods for the repopulation of organs and tissues, such as the liver, using modified cells that express a transcription coactivation...
2017/0246214 COMPOSITIONS AND METHODS FOR TRANSPLANTATION OF COLON MICROBIOTA
The present invention provides compositions that include an extract of human feces, and methods for using such compositions, including methods for replacing or...
2017/0246212 METHODS TO UPREGULATE AND SUPPRESS AN EXPRESSION OF IMMUNOMODULATORY CELLS
The present application provides a method of upregulating an expression of immumodulatory cells in vitro comprising treating the immumodulatory cells with...
2017/0246211 METHOD FOR EVALUATING MESENCHYMAL STEM CELL ACTIVITY, METHOD FOR CULTURING MESENCHYMAL STEM CELLS, METHOD FOR...
The present invention relates to a method for evaluating the activity level of mesenchymal stem cells, and a method for culturing mesenchymal stem cells using...
2017/0246210 EX-VIVO INDUCED REGULATORY MESENCHYMAL STEM CELLS OR MYELOID-DERIVED SUPPRESSOR CELLS AS IMMUNE MODULATORS
A composition comprising TGF.beta., an inflammatory agent and a tryptophan indoleamine-2,3 dioxygenase (IDO) metabolite, in particular, TGF.beta., IFN.gamma....
2017/0246209 TREATING VIRAL HEMORRHAGIC FEVER WITH NK-92 CELLS
This disclosure is directed to treatment of a patient having or suspected of having viral hemorrhagic fever, comprising administering to the patient NK-92 cells.
2017/0246208 SELECTIVE CYTOPHERESIS DEVICES AND RELATED METHODS THEREOF
The present invention relates to systems and devices to treat and/or prevent inflammatory conditions within a subject and to related methods. More...
2017/0246207 ANTIGEN SPECIFIC MRNA CELLULAR CANCER VACCINES
Disclosed are antigen specific cancer vaccines in which immunogenic epitopes are produced intracellularly by administration of modified mRNA encoding said...
2017/0246206 Calcium Formate for Use as a Dietary Supplement
A calcium formate composition for oral administration to an individual for the purpose of supplementary dietary calcium is disclosed.
2017/0246205 NITRIC OXIDE RELEASING BATH COMPOSITIONS AND METHODS OF USING THE SAME
The present invention relates to bath compositions that may release nitric oxide when combined with an aqueous solution, thereby producing a nitric oxide...
2017/0246204 MEDICAMENT FOR TREATING A DISEASE RELATING TO A DYSFUNCTION OF THE DOPAMINERGIC SYNAPTIC TRANSMISSION
The invention relates to a drug combination comprising gaseous xenon and at least one antagonist of the NMDA receptors in a liquid or solid form for treating a...
2017/0246203 PORTABLE, NITRIC OXIDE GENERATOR
An apparatus for portable delivery of nitric oxide without the need for pressurized tanks, power supplies, or other devices provides a single therapy session...
2017/0246202 PHARMACEUTICAL COMPOSITIONS AND METHODS RELATING TO INHIBITING FIBROUS ADHESIONS OR INFLAMMATORY DISEASE USING...
Compositions and methods involving administration of agents useful for the treatment, prevention, inhibition, etc., of inflammatory disease or fibrous...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.